{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:07:15Z","timestamp":1772896035633,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1007\/s11906-002-0048-8","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T20:14:42Z","timestamp":1180124082000},"page":"18-24","source":"Crossref","is-referenced-by-count":18,"title":["Genetics of the mineralocorticoid system in primary hypertension"],"prefix":"10.1007","volume":"4","author":[{"given":"Paolo","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"48_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11\u03b2-hydroxylase\/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262\u2013265.","journal-title":"Nature"},{"key":"48_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407\u2013414.","journal-title":"Cell"},{"key":"48_CR3","first-page":"2263","volume":"80","author":"RC Wilson","year":"1995","unstructured":"Wilson RC, Krozowski ZS, Li K, et al.: A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995, 80:2263\u20132266.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"DS Geller","year":"2000","unstructured":"Geller DS, Farhi A, Pinkerton N, et al.: Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000, 289:119\u2013123.","journal-title":"Science"},{"key":"48_CR5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(97)07306-6","volume":"351","author":"EH Baker","year":"1998","unstructured":"Baker EH, Dong YB, Sagnella GA, et al.: Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet 1998, 351:1388\u20131392. This is the first study showing a high prevalence of one single mutation in the ENaC in nonselected hypertensive subjects.","journal-title":"Lancet"},{"key":"48_CR6","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","volume":"95","author":"RC Wilson","year":"1998","unstructured":"Wilson RC, Dave-Sharma S, Wei JQ, et al.: A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A 1998, 95:10200\u201310205. This is a report showing that a point mutation causing a reduced activity of the 11\u03b2HSD2 enzyme was responsible for a mild form of hypertension in an adolescent girl.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR7","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1096\/fasebj.5.15.1743440","volume":"5","author":"PJ Fuller","year":"1991","unstructured":"Fuller PJ: The steroid receptor superfamily: mechanisms of diversity. Faseb J 1991, 5:3092\u20133099.","journal-title":"Faseb J"},{"key":"48_CR8","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1096\/fasebj.6.8.1592204","volume":"6","author":"H Gronemeyer","year":"1992","unstructured":"Gronemeyer H: Control of transcription activation by steroid hormone receptors. Faseb J 1992, 6:2524\u20132529.","journal-title":"Faseb J"},{"key":"48_CR9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.8382376","volume":"259","author":"D Pearce","year":"1993","unstructured":"Pearce D, Yamamoto KR: Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993, 259:1161- 1165.","journal-title":"Science"},{"key":"48_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.19.3.221","volume":"19","author":"JD Horisberger","year":"1992","unstructured":"Horisberger JD, Rossier BC: Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension 1992, 19:221\u2013227.","journal-title":"Hypertension"},{"key":"48_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, et al.: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583\u2013585.","journal-title":"Science"},{"key":"48_CR12","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC: Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966, 95:1109\u20131119.","journal-title":"Can Med Assoc J"},{"key":"48_CR13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","volume":"89","author":"T Kawamoto","year":"1992","unstructured":"Kawamoto T, Mitsuuchi Y, Toda K, et al.: Role of steroid 11\u03b2hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 1992, 89:1458\u20131462.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR14","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","volume":"89","author":"L Pascoe","year":"1992","unstructured":"Pascoe L, Curnow KM, Slutsker L, et al.: Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 1992, 89:8327\u20138331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ng0995-6","volume":"11","author":"RD Gordon","year":"1995","unstructured":"Gordon RD: Heterogeneous hypertension. Nat Genet 1995, 11:6\u20139.","journal-title":"Nat Genet"},{"key":"48_CR16","first-page":"4031","volume":"84","author":"M Stowasser","year":"1999","unstructured":"Stowasser M, Huggard PR, Rossetti TR, et al.: Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 1999, 84:4031\u20134036. This study demonstrates that in normotensive subjects with familial GRA, biochemical abnormalities are similar to those of hypertensive siblings. This suggests that gene-to-gene or gene-toenvironment interactions may play an important role in the development of hypertension.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jmg.33.1.25","volume":"33","author":"LJ Gates","year":"1996","unstructured":"Gates LJ, MacConnachie AA, Lifton RP, et al.: Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet 1996, 33:25\u201328.","journal-title":"J Med Genet"},{"key":"48_CR18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.33.2.703","volume":"33","author":"E Davies","year":"1999","unstructured":"Davies E, Holloway CD, Ingram MC, et al.: Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999, 33:703\u2013707. This study demonstrates that a single nucleotide polymorphism causing an increased sensitivity of the CYP11B2 gene to angiotensin II is associated with increased aldosterone secretion and hypertension in an unselected population.","journal-title":"Hypertension"},{"key":"48_CR19","first-page":"3570","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield WR, New MI, Coolidge C, et al.: Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid- remediable aldosteronism. J Clin Endocrinol Metab 1997, 82:3570\u20133573.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/mend.11.5.9920","volume":"11","author":"CD Clyne","year":"1997","unstructured":"Clyne CD, Zhang Y, Slutsker L, et al.: Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 1997, 11:638\u2013649.","journal-title":"Mol Endocrinol"},{"key":"48_CR21","first-page":"385","volume":"6","author":"EA Werder","year":"1974","unstructured":"Werder EA, Zachmann M, Vollmin JA, et al.: Unusual steroid excretion in a child with low renin hypertension. Res Steroids 1974, 6:385\u2013389.","journal-title":"Res Steroids"},{"key":"48_CR22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","volume":"49","author":"S Ulick","year":"1979","unstructured":"Ulick S, Levine LS, Gunczler P, et al.: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979, 49:757\u2013764.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR23","doi-asserted-by":"crossref","first-page":"18939","DOI":"10.1016\/S0021-9258(19)47248-7","volume":"264","author":"AK Agarwal","year":"1989","unstructured":"Agarwal AK, Monder C, Eckstein B, et al.: Cloning and expression of rat cDNA encoding corticosteroid 11\u03b2-dehydrogenase. J Biol Chem 1989, 264:18939\u201318943.","journal-title":"J Biol Chem"},{"key":"48_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/07435809509030456","volume":"21","author":"AL Albiston","year":"1995","unstructured":"Albiston AL, Smith RE, Obeyesekere VR, et al.: Cloning of the 11 beta HSD type II enzyme from human kidney. Endocrinol Res 1995, 21:399\u2013409.","journal-title":"Endocrinol Res"},{"key":"48_CR25","doi-asserted-by":"crossref","first-page":"16653","DOI":"10.1016\/S0021-9258(18)55351-5","volume":"266","author":"GM Tannin","year":"1991","unstructured":"Tannin GM, Agarwal AK, Monder C, et al.: The human gene for 11\u03b2-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 1991, 266:16653\u201316658.","journal-title":"J Biol Chem"},{"key":"48_CR26","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","volume":"105","author":"AL Albiston","year":"1994","unstructured":"Albiston AL, Obeyesekere VR, Smith RE, et al.: Cloning and tissue distribution of the human 11\u03b2-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994, 105:R11-R17.","journal-title":"Mol Cell Endocrinol"},{"key":"48_CR27","doi-asserted-by":"crossref","first-page":"25959","DOI":"10.1016\/S0021-9258(18)47142-6","volume":"269","author":"AK Agarwal","year":"1994","unstructured":"Agarwal AK, Mune T, Monder C, et al.: NAD(+)-dependent isoform of 11\u03b2-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J Biol Chem 1994, 269:25959\u201325962.","journal-title":"J Biol Chem"},{"key":"48_CR28","first-page":"2203","volume":"80","author":"Z Krozowski","year":"1995","unstructured":"Krozowski Z, MaGuire JA, Stein-Oakley AN, et al.: Immunohistochemical localization of the 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 1995, 80:2203\u20132209.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","volume":"10","author":"T Mune","year":"1995","unstructured":"Mune T, Rogerson FM, Nikkila H, et al.: Human hypertension caused by mutations in the kidney isozyme of 11\u03b2-hydroxysteroid dehydrogenase. Nat Genet 1995, 10:394\u2013399.","journal-title":"Nat Genet"},{"key":"48_CR30","first-page":"3145","volume":"80","author":"RC Wilson","year":"1995","unstructured":"Wilson RC, Harbison MD, Krozowski ZS, et al.: Several homozygous mutations in the gene for 11\u03b2-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995, 80:3145\u20133150.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(96)03787-2","volume":"119","author":"P Ferrari","year":"1996","unstructured":"Ferrari P, Obeyesekere VR, Li K, et al.: Point mutations abolish 11\u03b2-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol Cell Endocrinol 1996, 119:21\u201324.","journal-title":"Mol Cell Endocrinol"},{"key":"48_CR32","first-page":"3745","volume":"84","author":"E Lovati","year":"1999","unstructured":"Lovati E, Ferrari P, Dick B, et al.: Molecular basis of human salt-sensitivity: the role of the 11\u03b2-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 1999, 84:3745\u20133749. This is the first study linking a molecular variant of a gene (11\u03b2HSD2) resulting in a biochemical abnormality (decreased cortisol metabolism) to an increased sensitivity of blood pressure to high salt intake.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1046\/j.1523-1755.2000.00303.x","volume":"58","author":"T Zaehner","year":"2000","unstructured":"Zaehner T, Plueshke V, Frey BM, et al.: Structural analysis of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene in endstage renal disease. Kidney Int 2000, 58:1413\u20131419.","journal-title":"Kidney Int"},{"key":"48_CR34","first-page":"199","volume":"76","author":"GW Liddle","year":"1963","unstructured":"Liddle GW, Bledsoe T, Coppage WSJ: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physicians 1963, 76:199\u2013213.","journal-title":"Trans Am Assoc Physicians"},{"key":"48_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM199401203300305","volume":"330","author":"M Botero-Velez","year":"1994","unstructured":"Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle\u2019s syndrome revisited--a disorder of sodium reabsorption in the distal tubule. N Engl J Med 1994, 330:178\u2013181.","journal-title":"N Engl J Med"},{"key":"48_CR36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-52-5-1027","volume":"52","author":"C Wang","year":"1981","unstructured":"Wang C, Chan TK, Yeung RT, et al.: The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle\u2019s syndrome. J Clin Endocrinol Metab 1981, 52:1027\u20131032.","journal-title":"J Clin Endocrinol Metab"},{"key":"48_CR37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng0995-76","volume":"11","author":"JH Hansson","year":"1995","unstructured":"Hansson JH, Nelson-Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995, 11:76\u201382.","journal-title":"Nat Genet"},{"key":"48_CR38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(95)90212-0","volume":"83","author":"PM Snyder","year":"1995","unstructured":"Snyder PM, Price MP, McDonald FJ, et al.: Mechanism by which Liddle\u2019s syndrome mutations increase activity of a human epithelial Na+ channel. Cell 1995, 83:969\u2013978.","journal-title":"Cell"},{"key":"48_CR39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/00004872-199612000-00005","volume":"14","author":"H Chang","year":"1996","unstructured":"Chang H, Fujita T: Lack of mutations in epithelial sodium channel \u03b2-subunit gene in human subjects with hypertension. J Hypertens 1996, 14:1417\u20131419.","journal-title":"J Hypertens"},{"key":"48_CR40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.HYP.31.5.1118","volume":"31","author":"O Melander","year":"1998","unstructured":"Melander O, Orho M, Fagerudd J, et al.: Mutations and variants of the epithelial sodium channel gene in Liddle\u2019s syndrome and primary hypertension. Hypertension 1998, 31:1118\u20131124.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-002-0048-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0048-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T07:15:19Z","timestamp":1628925319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-002-0048-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1007\/s11906-002-0048-8","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}